Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myoclonus.

Victoria C Chang1, Steven J Frucht

  • 1Victoria C. Chang, MD Neurological Institute, Columbia University Medical Center, 710 West 168th Street, 3rd Floor, New York, NY 10032, USA. vchang@neuro.columbia.edu.

Current Treatment Options in Neurology
|June 27, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Point of view: Task-specific movement disorders-time for a reappraisal?

Parkinsonism & related disorders·2026
Same author

RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications.

Movement disorders : official journal of the Movement Disorder Society·2025
Same author

Myoclonus, dystonia and parkinsonism due to a de novo novel variant in the NUS1 gene: Furthering the epilepsy-dyskinesia spectrum - Expert commentary.

Parkinsonism & related disorders·2025
Same author

Deep Phenotyping of Musicians' Upper Limb Dystonia.

Tremor and other hyperkinetic movements (New York, N.Y.)·2025
Same author

The Spectrum of Neurologic Phenotypes Associated With NUS1 Pathogenic Variants: A Comprehensive Case Series.

Annals of neurology·2025
Same author

Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS]).

Movement disorders : official journal of the Movement Disorder Society·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Myoclonus, a movement disorder causing involuntary jerks, presents diagnostic and treatment challenges. Current research explores new therapies and diagnostic tools for this debilitating condition.

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Myoclonus is a hyperkinetic movement disorder with diverse causes and locations.
  • Current treatments are often partially effective and lack strong evidence.
  • Non-cortical myoclonus has less established treatment evidence compared to cortical forms.

Purpose of the Study:

  • To review current investigations into myoclonus.
  • To provide updated diagnostic and treatment guidelines for myoclonus.

Main Methods:

  • Review of recent literature on myoclonus therapy.
  • Analysis of ongoing research including animal models, electrophysiology, imaging (e.g., diffusion tensor imaging), and genetics.

Main Results:

  • Therapeutic options for myoclonus are limited and often lack robust evidence.

Related Experiment Videos

  • Research is advancing in understanding and potentially treating myoclonus.
  • Diagnostic approaches remain largely traditional.

    • Conclusions:

    • Effective treatments for myoclonus are needed.
    • Continued research is crucial for improving patient outcomes.
    • Updated diagnostic and treatment guidelines are proposed.